Core Insights - Keiretsu Forum Mid-Atlantic, South-East, and Texas (K4-MST) and MDB Capital Holdings successfully hosted two investor-focused events aimed at transforming early-stage capital approaches [1][2] Group 1: Event Overview - The Southeast Investor Conference took place on July 29-30 at Georgia Tech, focusing on accredited investors and family offices, featuring educational sessions and structured networking [3][5] - The Mid-Atlantic Investor Summit was held on November 19-20 at Drexel University, emphasizing disciplined portfolio strategies and faster exits [5][6] Group 2: Key Themes and Discussions - Both events aimed to shift discussions from market challenges to collaborative solutions, showcasing curated deal flow and real data on returns [4][10] - The conferences included presentations from approximately 75 accredited investors and showcased 10 diligence-ready companies, focusing on sectors like AI, MedTech, and FinTech [7][8] Group 3: Future Plans - K4-MST and MDB Capital announced plans for a series of Investor Summits in 2026, with events scheduled in Dallas, Atlanta, and Philadelphia [10][15] - The upcoming summits will continue to emphasize syndication, investor education, and pathways to quicker exits, aiming to align angel investing with public venture pathways [14][15]

Core Insights - MDB Capital Holdings, LLC will present at the LD Micro Main Event XIX on October 21st at 10:30 AM PT, marking a significant milestone as the 2,000th company to present at this event [1][3] Company Overview - MDB Capital Holdings, founded in 1997, focuses on launching "Big Ideas" through public venture capital, emphasizing community-driven financings for early-stage leaders in significant business and technology sectors [6][7] - The firm operates under the MDB Capital brand, which includes subsidiaries like MDB Capital, a venture-focused broker-dealer, and PatentVest, an integrated IP strategy and law firm [7] Event Details - The LD Micro Main Event XIX will take place from October 19th to 21st at the Hotel del Coronado in San Diego, California, featuring around 120 companies presenting in half-hour increments [4][5] - The event will include registration, keynote speakers, company presentations, one-on-one investor meetings, and a closing reception [4]

Company Overview and Strategy - MDB Capital aims to transform deep technology "Big Ideas" into valuable public companies[6] - The company's goal is to enable investors to create a portfolio of 10–12 MDB curated venture-stage companies over time[7] - MDB's platform helps stand up and launch deep tech new category leaders[10] Pipeline and Due Diligence - In 2024, MDB screened 8,964 private and public companies and further examined 219 to identify deep tech ideas[21] - The number of private companies reviewed increased by 107% from 3,391 in 2023 to 7,025 in 2024[22] - The number of public companies under surveillance increased by 35% from 1,432 in 2023 to 1,939 in 2024[22] - Companies further examined increased by 366% from 47 in 2023 to 219 in 2024[22] Financial Performance and Investments - MDB's direct assets increased significantly by 2,092% from $2,016,959 in 2023 to $44,215,968 in 2024[22] - The company completed an IPO for Invizyne Technologies (now eXoZymes Inc (EXOZ)) in November 2024, raising $15 million[21,40] - MDB's initial investment of $5.9 million in eXoZymes translated into a $150 million market cap company[40] - MDB owns 47% of eXoZymes' outstanding stock[40] Market Positioning and Future Outlook - MDB is well-positioned for 2025 due to a significant increase in micro-cap deal opportunities and a growing demand for micro-cap financing[29,34] - Venture Capital fundraising declined by nearly 58% in 2023 and by 23-25% in 2024[31]

Core Insights - MDB Capital Holdings, LLC is focused on launching deep technology companies and has made significant progress in a challenging venture market, highlighting the value of its public venture approach [2][6] Operational Highlights - The company successfully completed its first full year of its clearing and trading platform and has expanded its investor community by 12%, onboarding 456 new brokerage accounts and increasing assets under management from approximately $2 million to $44 million [6] - MDB Capital launched an initial public offering for eXoZymes Inc, a company spun out from UCLA, and currently owns about 47% of its outstanding shares [6] - The firm increased its analyst team to 14, screening 8,964 companies and examining 217 for potential market leadership, resulting in a strong pipeline of "Big Ideas" [6] - MDB Capital operates a self-clearing broker-dealer and an online investment platform specifically for public venture investing, enhancing its service offerings [6][8] Financial Reporting - The company filed its Form 10-K with the SEC, which includes consolidated financial results for all operations, including eXoZymes' performance until its IPO on November 14, 2024 [6]

As filed with the Commission on October 21, 2024 Registration No. 333-276987 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 8 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INVIZYNE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Nevada 2836 47-228900 (I.R.S. Employer Identification No.) 750 Royal Oaks Dri ...